Market research
MDC.LSE Mediclinic International plc
LSE GBP Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 4B
- P/E ratio
- 21.78
- Analyst target
- 416.6
- Dividend yield
- 0.6%
- Beta
- 0.42
Profile
Company facts
- Exchange
- LSE
- Currency
- GBP
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- ISIN
- GB00B8HX8Z88
- Market cap
- 4B
- P/E ratio
- 21.78
- Analyst target
- 416.6
- Dividend yield
- 0.6%
- Beta
- 0.42
About
About Mediclinic International plc
Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers specialist-orientated and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 20 day case clinics, 22 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 453 theatres with approximately 11,538 inpatient beds in Switzerland, South Africa, Namibia, the Middle East, and the United Kingdom. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in the intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the MDC.LSE discussion.
5 years, 5 months ago
Mediclinic International plc is currently in a long term downtrend where the price is trading 1.0% below its 200 day moving average.
From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Mediclinic International plc's total revenue sank by 0.0% to $758M since the same quarter in the previous year.
Its net income has dropped by 0.0% to $54M since the same quarter in the previous year.
Finally, its free cash flow fell by 134.6% to $-18M since the same quarter in the previous year.
Based on the above factors, Mediclinic International plc gets an overall score of 1/5.